Heart Care Associates, P.C.

Hopewell, Virginia 23860

1 studies enrolling now · 8 studies all time

What they study most

Acute Coronary Syndrome, Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Hyperlipidemia, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Pelacarsen Roll-over Extension Program — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia — Completed
• Phase III Acute Coronary Syndrome — Stopped early